Home

Cencora, Inc. Common Stock (COR)

278.39
-10.97 (-3.79%)
NYSE · Last Trade: Apr 5th, 2:05 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Cencora, Inc. Common Stock (COR)

AmerisourceBergen Corporation

AmerisourceBergen Corporation provides pharmaceutical distribution and related services, positioning itself in direct competition with Cencora. Like McKesson, AmerisourceBergen has a comprehensive logistics and distribution network which allows it to serve a wide range of healthcare providers efficiently. The company differentiates itself through strategic partnerships and a focus on specialty pharmaceuticals, which can provide a competitive advantage in certain drug markets. However, it operates in a similar space as Cencora, making them comparable competitors.

Catalent, Inc. CTLT +0.00

Catalent, Inc. is a direct competitor of Cencora, primarily focusing on advanced delivery technologies and manufacturing solutions for drugs and biologics. Both companies operate in the biopharmaceutical supply chain, but Catalent's strong emphasis on innovation in drug development processes and its extensive network of development and manufacturing facilities give it a competitive advantage. Catalent's well-rounded services help speed up the product's time to market, which can be an attractive factor for biopharmaceutical clients.

GE Healthcare GE -11.10%

GE Healthcare competes with Cencora by focusing on advanced medical imaging, monitoring, and diagnostics solutions. While Cencora emphasizes logistics and supply chain management in the healthcare sector, GE Healthcare leverages its expertise in imaging technology to provide integrated and innovative solutions that improve patient outcomes. GE's longstanding relationships with hospitals and healthcare institutions provide it a competitive edge, allowing it to maintain and grow its customer base significantly.

McKesson Corporation MCK -4.72%

McKesson Corporation competes with Cencora primarily in pharmaceutical distribution and healthcare management solutions. As one of the largest pharmaceutical distributors in North America, McKesson has a competitive advantage due to its extensive logistics infrastructure and established relationships with healthcare providers. While Cencora focuses on certain niche areas, McKesson's large-scale operations, broad product offerings, and capabilities in pharmaceutical supply chain management allow it to dominate the market.

Thermo Fisher Scientific Inc. TMO -6.83%

Thermo Fisher Scientific Inc. is a leader in the life sciences industry, competing with Cencora, Inc. by offering a comprehensive range of services and products that cover research, clinical, and commercial supply chains. Their robust capabilities in laboratory equipment, reagents, and analytics give them a significant edge in terms of technological advancement and product diversity. Thermo Fisher's established brand reputation and extensive market reach allow it to attract a wide range of customers in need of comprehensive solutions, highlighting its competitive advantage over Cencora.